Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Nuclera Raises Series C Funding to $87 Million to Expand Antibody Engineering Platform
Life Sciences Times
-
January 13, 2026
0
Venture Capital
MEDIPOST Secures $140 Million to Advance U.S. Phase III Stem Cell Trial
Life Sciences Times
-
January 9, 2026
0
Venture Capital
Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs
Life Sciences Times
-
January 8, 2026
0
Venture Capital
Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform
Life Sciences Times
-
January 8, 2026
0
Venture Capital
Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth
Life Sciences Times
-
January 8, 2026
0
Venture Capital
Corsera Health Raises $80 Million Series A and Begins First Clinical Trial
Life Sciences Times
-
January 7, 2026
0
Venture Capital
Nocion Therapeutics Expands Series B to $93 Million to Advance Late-Stage Development of Taplucainium for Chronic Cough
Life Sciences Times
-
January 7, 2026
0
Venture Capital
Prudentia Sciences Raises $20 Million Series A to Advance AI-Driven Due Diligence in Life Sciences Dealmaking
Life Sciences Times
-
January 7, 2026
0
Pharma
Helus Pharma Rebrands and Begins Trading on Nasdaq as It Advances Mental Health Drug Portfolio
Life Sciences Times
-
January 5, 2026
0
Venture Capital
Johnson & Johnson Completes Acquisition of Halda Therapeutics
Life Sciences Times
-
December 29, 2025
0
Venture Capital
Startup Shutdowns Shift to Later Stages as First AI Reckoning Emerges, Report Finds
Life Sciences Times
-
December 23, 2025
0
Venture Capital
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx in $55.5 Million Deal
Life Sciences Times
-
December 23, 2025
0
1
...
4
5
6
...
115
Page 5 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026